Literature DB >> 10159007

Global healthcare financing for type II diabetes: are there ways out of the crisis?

T D Szucs1.   

Abstract

This article focuses on the overall situation with regard to healthcare financing in the field of diabetes. Worldwide efforts on cost containment have severely influenced the management of chronic illness. An answer as to whether or not the expected financial crisis can be prevented will be difficult to obtain. However, use of the modern tools of management sciences and health economics can bring more transparency into the picture. Solutions will have to be based increasingly on empirical economic data, which, so far, are only in the process of being generated in many countries. A research agenda is proposed that might trigger the compilation of additional data in order to ensure adequate future financing of diabetes care.

Entities:  

Mesh:

Year:  1995        PMID: 10159007     DOI: 10.2165/00019053-199500081-00014

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  18 in total

Review 1.  Multi-attribute preference functions. Health Utilities Index.

Authors:  G W Torrance; W Furlong; D Feeny; M Boyle
Journal:  Pharmacoeconomics       Date:  1995-06       Impact factor: 4.981

2.  Selection and evaluation of empirical research in technology assessment.

Authors:  T C Chalmers; P Hewett; D Reitman; H S Sacks
Journal:  Int J Technol Assess Health Care       Date:  1989       Impact factor: 2.188

Review 3.  A clinician's guide to cost-effectiveness analysis.

Authors:  A S Detsky; I G Naglie
Journal:  Ann Intern Med       Date:  1990-07-15       Impact factor: 25.391

4.  Incorporating patients' preferences into medical decisions.

Authors:  J P Kassirer
Journal:  N Engl J Med       Date:  1994-06-30       Impact factor: 91.245

Review 5.  Prevention and treatment of the complications of diabetes mellitus.

Authors:  C M Clark; D A Lee
Journal:  N Engl J Med       Date:  1995-05-04       Impact factor: 91.245

6.  The economic costs of non-insulin-dependent diabetes mellitus.

Authors:  D M Huse; G Oster; A R Killen; M J Lacey; G A Colditz
Journal:  JAMA       Date:  1989-11-17       Impact factor: 56.272

7.  Diabetes--the cost of illness and the cost of control. An estimate for Sweden 1978.

Authors:  B Jönsson
Journal:  Acta Med Scand Suppl       Date:  1983

8.  Effects of a limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia.

Authors:  S B Soumerai; T J McLaughlin; D Ross-Degnan; C S Casteris; P Bollini
Journal:  N Engl J Med       Date:  1994-09-08       Impact factor: 91.245

9.  The appropriateness of use of percutaneous transluminal coronary angioplasty in New York State.

Authors:  L H Hilborne; L L Leape; S J Bernstein; R E Park; M E Fiske; C J Kamberg; C P Roth; R H Brook
Journal:  JAMA       Date:  1993-02-10       Impact factor: 56.272

10.  The appropriateness of use of coronary angiography in New York State.

Authors:  S J Bernstein; L H Hilborne; L L Leape; M E Fiske; R E Park; C J Kamberg; R H Brook
Journal:  JAMA       Date:  1993-02-10       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.